Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,189 | 90,947 | 201,648 | 135,897 | 111,154 |
| Marketable Securities | 289,081 | 304,405 | 300,527 | 416,033 | 434,171 |
| Receivables | 18,049 | 18,608 | 21,821 | 13,896 | 11,814 |
| Inventories | 7,253 | 8,206 | 7,090 | 5,716 | 4,596 |
| TOTAL | $385,294 | $437,143 | $546,632 | $584,031 | $571,458 |
| Non-Current Assets | |||||
| PPE Net | 10,820 | 9,588 | 9,633 | 9,583 | 9,925 |
| Investments And Advances | 53,028 | 58,707 | 3,102 | 12,477 | 41,114 |
| Other Non-Current Assets | 34,276 | 35,128 | 35,879 | 36,341 | 37,171 |
| TOTAL | $98,124 | $103,423 | $48,614 | $58,401 | $88,210 |
| Total Assets | $483,418 | $540,566 | $595,246 | $642,432 | $659,668 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,502 | 14,022 | 11,905 | 12,308 | 10,237 |
| Accrued Expenses | 59,625 | 49,428 | 49,344 | 55,227 | 48,941 |
| TOTAL | $75,789 | $66,054 | $63,789 | $69,992 | $61,188 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,172 | 27,856 | 28,444 | 28,764 | 29,394 |
| TOTAL | $27,172 | $27,856 | $28,444 | $28,764 | $29,394 |
| Total Liabilities | $102,961 | $93,910 | $92,233 | $98,756 | $90,582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,481 | 58,041 | 57,965 | 57,626 | 56,933 |
| Common Shares | 583 | 580 | 579 | 576 | 566 |
| Retained earnings | -966,037 | -886,199 | -815,766 | -754,468 | -691,728 |
| Other shareholders' equity | 165 | 26 | 43 | 11 | 39 |
| TOTAL | $380,457 | $446,656 | $503,013 | $543,676 | $569,086 |
| Total Liabilities And Equity | $483,418 | $540,566 | $595,246 | $642,432 | $659,668 |